High CIBERSORT-derived CD8+ T-cell abundance was significantly associated with improved overall survival in the DLBCL cohort, with a mean ± SE of 107.32 ± 16.45 vs. 52.57 ± 13.62 (p < 0.01; Figure 4B). This evidence concerns the gene CD8A and diffuse large B-cell lymphoma.